Type
Business expansion
Country
France
Region
Centre — Val de Loire; Centre — Val de Loire; Eure-et-Loir
Location of affected unit(s)
Chartres
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21.2 - Manufacture of pharmaceutical preparations
21.2 - Manufacture of pharmaceutical preparations

100 jobs
Number of planned job creations
Job creation
Announcement Date
11 August 2026
Employment effect (start)
1 September 2026
Foreseen end date
31 December 2026

Description

Gi Life Sciences Chartres, a subsidiary of the Italian Gi Group Holding, announced in November 2026 a recruitment campaign for 100 production operators at its Chartres manufacturing site by the end of 2026, as part of a broader plan to create 500 jobs by 2030. The expansion will increase capacity to meet growing pharmaceutical demand. All new hires will work in the Chartres facility’s controlled atmosphere production zone and will be trained for aseptic manufacturing standards. The initiative reinforces Gi Life Sciences Chartres’ commitment to local employment and supports Gi Group Holding’s strategy of expanding its presence in France.


Citation

Eurofound (2026), Gi Life Sciences Chartres, Business expansion in France, factsheet number 300858, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300858.